Concepedia

Kathryn R. Rigonan

KR

Statistics

Publications

3

Citations

98

H-Index

3

Active since

1993

Affiliations

Vanderbilt University Medical Center(Current)

Emory University

Merck & Co., Inc., Rahway, NJ, USA (United States)

Kathryn R. Rigonan is an author at Vanderbilt University Medical Center specializing in vaccination, vaccine immunology, and vaccinology.

Publications per year

1993–2024

3

Publications

3

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

Heather Platt, Christopher Bruno, Erik Buntinx et al. · The Lancet Infectious Diseases · 2024 · 53 citations

, , +16

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine–Experienced Adults 50 Years of Age or Older (STRIDE-6)

Paul T. Scott, Miwa Haranaka, Jung‐Hyun Choi et al. · Clinical Infectious Diseases · 2024 · 33 citations · Full text

, , +17

Increased blood pressure and neural tone in the silent ischemia of hypertension: Disparate effects of immediate release nifedipine

Debora De-Ping Lee, Kathryn R. Rigonan, Vincent DeQuattro · Journal of the American College of Cardiology · 1993 · 12 citations

, , +13

1–3 of 3